AABB Audioconference Schedule
Pathogen Reduction - Blood Center & Hospital Perspectives and Lessons Learned (Wed., 5/16/18)
Samantha E. Mack, MD, Medical Director, Bonfils Blood Center, United Blood Services, Denver, CO
Justin D. Kreuter, MD, Consultant, Transfusion Medicine, Medical Director, Blood Donor Program, Associate Medical Director, Histocompatibility Laboratory, Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN;
Patricia Kopko, M.D., Director, Transfusion Medicine, Associate Director, Immunogenetics and Transplantation Laboratory, University of California, San Diego, CA
- Review experience of implementing pathogen reduced platelets at a Blood Center including optimizing collection platform settings and increasing the availability of platelets to pathogen reduce by splitting larger collections to meet set guard bands.
- Discuss gauging hospital interest and demand for pathogen reduction in the current environment including a review of cost related issues.
- Identify at least two lessons learned by the hospital transfusion service when implementing pathogen reduced products
- Describe the development of a policy regarding providing pathogen reduced platelets to patients in the setting of a dual inventory.
Pathogen reduction is being implemented throughout the US to mitigate transfusion-transmitted infectious risks. Multiple US blood centers are either already distributing or are preparing to distribute pathogen reduced platelets to hospitals. In this program, the speakers will review their experiences in implementing pathogen reduction at their Blood Center and/or Hospital Transfusion Service. They will discuss challenges faced and lessons learned by their respective institution’s including methods to optimize production at the Blood Center and managing a dual inventory in the Transfusion Service.